RARE: Ultragenyx Pharmaceutical Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,857.43
Enterprise Value ($M) 3,643.84
Book Value ($M) 31.71
Book Value / Share 0.39
Price / Book 121.63
NCAV ($M) -483.42
NCAV / Share -5.87
Price / NCAV -7.98

Profitability (mra)
Return on Invested Capital (ROIC) -8.10
Return on Assets (ROA) -0.39
Return on Equity (ROE) -1.29

Liquidity (mrq)
Quick Ratio 2.49
Current Ratio 2.61

Balance Sheet (mrq) ($M)
Current Assets 732.18
Assets 1,491.01
Liabilities 1,215.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 434.25
Operating Income -569.21
Net Income -606.64
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -474.81
Cash from Investing 168.00
Cash from Financing 388.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/ 4.20 -15.69
02-14 13G/A Rtw Investments, Lp 8.40 73.61
02-13 13G/A Vanguard Group Inc 10.56 19.86
02-13 13G Sands Capital Management, Llc 5.00
02-08 13G/A Wellington Management Group Llp 5.38 -15.14
01-29 13G/A BlackRock Inc. 6.40 20.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-21 10-K Form 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 129,976 421,655 30.83
2024-03-26 32,953 362,335 9.09
2024-03-25 65,993 442,715 14.91
2024-03-22 47,046 403,665 11.65

(click for more detail)

Similar Companies
QDEL – QuidelOrtho Corporation QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V. RDUS – Radius Recycling, Inc.
REGN – Regeneron Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io